Search for: "WYETH PHARMACEUTICALS INC"
Results 161 - 180
of 515
Sorted by Relevance
|
Sort by Date
9 Aug 2012, 5:00 am
Nittany Pharmaceuticals (?) [read post]
2 Mar 2012, 6:52 am
Bard, Inc. [read post]
2 Feb 2012, 8:53 pm
Bard, Inc. [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
2 Jan 2008, 9:05 pm
Colony Pharmaceuticals, Inc. et al Wyeth v. [read post]
25 May 2010, 12:51 pm
Wyeth, Inc. [read post]
23 Aug 2012, 12:47 pm
Wyeth Pharmaceutical, Inc., 2009 WL 648703, at *2 (N.D. [read post]
20 Sep 2011, 6:35 am
Wyeth, Inc., ___ F.3d ___, 2011 WL 4389211, slip op. (6th Cir. [read post]
2 Aug 2012, 10:17 am
Liggett Group, Inc., 505 U.S. 504 (1992)—that federal law does not preempt state law design-defect claims targeting generic pharmaceutical products because the conceded conflict between such claims and the federal laws governing generic pharmaceutical design allegedly can be avoided if the makers of generic pharmaceuticals simply stop making their products. [read post]
23 Jun 2010, 10:28 pm
Anchen Pharmaceuticals, Inc. [read post]
20 Oct 2011, 5:39 am
A year later, in Wyeth v. [read post]
31 Jan 2011, 8:10 am
Kappos, to Ariad Pharmaceuticals v. [read post]
31 Jan 2011, 8:10 am
Kappos, to Ariad Pharmaceuticals v. [read post]
22 Jun 2010, 6:56 am
On Scroggin's behalf, personal injury product liability attorneys sued drug makers Wyeth Pharmaceuticals and Upjohn Co., both now subsidiaries of Pfzier Inc., claiming that hormone replacement drugs they manufactured were responsible for Scroggin's breast cancer. [read post]
28 Jun 2016, 9:02 am
Wyeth Inc., in ruling in 2008 that the maker of a drug called Reglan could be liable to a plaintiff who used the generic version.The state supreme court declined to hear the Conte case, so this will be the first time that court will consider a challenge like this. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
29 Mar 2007, 4:46 am
Wyeth Labs., Inc., 161 N.J. 1, 25 (1999). [read post]
27 Aug 2010, 2:41 pm
Ortho Pharmaceutical Corp., 209 Cal. [read post]
13 Jan 2010, 3:00 am
Cobrek Pharmaceuticals, Inc (Patent Docs) Nexium (Esomeprazole) – US: Teva drops patent challenge following settlement agreement with AstraZeneca over Nexium (IP Factor) (GenericsWeb) Nuvigil (Armodafinil) - US: Mylan confirms first-to-file patent challenge relating to sleep-disorder drug (SmartBrief) Nuvigil (Armodafinil) - US: Cephalon sues Watson for patent infringement following Para IV challenge (Patent Docs) (GenericsWeb) (Patentcircle) Tasigna (Nilotinib) - India:… [read post]